PubMed Health⌕ Search

Biomedical subjects

D W Porter

Publications and source records attributed to D W Porter.

At least 37 records · Page 2Linked to original sources
PubMed1993

Taurine regulation of Ca2+ uptake and (Ca(2+)+Mg2+)-ATPase in developing chick B-cells.

1. The objective of the present study was to determine the effect of age and taurine on chick B cell calcium uptake and membrane (Ca(2+)+Mg2+)-ATPase activity in 1-4-week-old chicks. 2. The calcium uptake rate decreased with age (P < 0.05) and was further decreased by taurine (P < 0.05). 3. (Ca(2+)+Mg2+)-ATPase activity increased with age (P < 0.05) and was stimulated by taurine (P < 0.05). 4. The data demonstrate that the flux of calcium across the B-cell membrane changes during early post-hatch development, and that taurine regulates both the influx and efflux of calcium in chick B-cells.

Animals↗
PubMed1993

The effect of taurine on the incorporation of thymidine by chick B cells.

1. This study was conducted to determine the effect of extracellular taurine on chick B cell proliferation as measured by the incorporation of [3H] thymidine. 2. B cells were cultured in RPMI-1640 media containing bacterial lipopolysaccharide and either 0 or 100 microM taurine. 3. Thymidine incorporation was significantly increased in the presence of 100 microM extracellular taurine. 4. These results suggest a role for taurine in the chick B cell proliferation process.

Animals↗
PubMed1993

Endocrine actions of central neuropeptide Y in the ewe: activation of the hypothalamo-pituitary-adrenal axis by exogenous neuropeptide Y and role of endogenous neuropeptide Y in the secretion of luteinizing hormone during the oestrous cycle.

Neurons immunoreactive for neuropeptide Y (NPY) are abundant in the hypophysiotrophic areas of the brain. In particular, there is considerable anatomical evidence for the influence of this neuropeptide on the reproductive and hypothalamo-pituitary-adrenal axes. We therefore investigated whether central administration of NPY can alter the activities of the reproductive and hypothalamopituitary-adrenal axes in the ewe, and whether ovarian steroids are involved in the modulation of these events. We also attempted to investigate whether endogenous NPY is important in the control of luteinizing hormone-releasing hormone/luteinizing hormone (LHRH/LH) secretion in the sheep oestrous cycle. Central injection of NPY (0.15 and 1.5 nmol in 50 microliters saline), delivered by gravity flow into the third cerebral ventricle, had no effect on LH levels in ovariectomized (OVX) ewes (n = 6) or OVX ewes implanted with oestradiol (OVX/E2) (n = 7), nor was LH secretion altered by central NPY (1.5 nmol) in intact cycling animals in either the follicular or the luteal phase (n = 5). However, central administration of 1.5 nmol NPY to intact ewes during both the follicular (P < 0.05) and the luteal phase (P < 0.01), and in OVX/E2 ewes (P < 0.05) caused a large and significant increase in plasma cortisol levels. High titre antibodies were raised to NPY in sheep and the effects of peripheral and central (intracerebroventricular) administration of anti-NPY antibodies on the timing and/or characteristics of the E2-induced LH surge in anoestrous ewes and of the preovulatory surge of LH in cycling ewes were determined. Intravenous administration of anti-NPY antibodies (n = 6) had no effect on the oestradiol benzoate-induced LH surge, compared with the control injection of non-immune plasma (n = 6). Likewise, passive systemic immunization against NPY (n = 10) was without effect on the characteristics of the preovulatory LH surge, compared with the control group (n = 10). However, central (intracerebroventricular) administration of anti-NPY antibodies (n = 4) delayed or abolished the preovulatory LH surge when compared with non-immune plasma treatment in the same animals. In summary, tonic LHRH/LH secretion is unaffected by centrally administered NPY at the doses used in this study. However, the same doses of NPY activate the hypothalamo-pituitary-adrenal axis, thus lending clear support to the hypothesis that NPY is involved in the multifactorial regulation of adrenocorticotrophin and cortisol secretion in this species, probably by stimulating corticotrophin-releasing hormone and/or arginine vasopressin secretion within the hypothalamus.(ABSTRACT TRUNCATED AT 400 WORDS)

Animals↗
PubMed1992

Taurine flux in chicken erythrocytes.

1. The intracellular taurine concentration in chick erythrocytes increased with age. 2. Erythrocyte taurine influx and efflux rates increased with age. 3. Erythrocyte taurine influx decreased when the extracellular sodium concentration was below normal physiological concentrations. 4. Under hypo-osmotic conditions, taurine efflux from erythrocytes increased. 5. The data suggest that chick erythrocyte taurine metabolism changes during early post-hatch development and that one taurine function may be as an osmoregulator.

Aging↗
PubMed1992

Taurine uptake into chick B cells.

The objective of the present study was to determine whether chick B cells possess a specific transport system for taurine. The Bursa of Fabricius was isolated from newly hatched to 6-week-old chicks and an enriched fraction (86.2%) of B cells was isolated. The chick B cells maintained a high intracellular taurine concentration (0.8-1.12 mM) that decreased with age. The B cells exhibited carrier-mediated and simple diffusion uptake components, but only the carrier-mediated component increased with age. Inhibitor studies indicated taurine uptake was sodium and energy dependent. The data demonstrate that chick B cells possess a specialized taurine transport system and the activity of this system changes during posthatch B cell development.

Aging↗
PubMed1991

Taurine uptake in chicken leukocytes and erythrocytes.

1. The intracellular taurine concentration and rate of taurine uptake of chicken erythrocytes and two leukocyte populations were determined from one to six weeks of age. 2. Plasma taurine concentrations increased significantly from the time of hatching to week 2 and remained constant thereafter. 3. Intracellular taurine concentrations in both leukocyte populations increased significantly with age without any significant change in the erythrocytes. 4. Taurine uptake rate for erythrocytes was significantly higher at weeks 1-3 while both leukocyte populations showed no significant change during the six week period studied.

Animals↗
PubMed1991

Taurine content of isolated rat alveolar type I cells.

1. Rat alveolar type I cells were isolated by enzymatic digestion and purified by centrifugal elutriation and specific surface adsorption. 2. The identity of the harvested cells was confirmed using electronic cell sizing and transmission electron microscopy. 3. Purified cell preparations contained 4.6 +/- 2.3 x 10(6) type I cells/rat lung with a purity of 79 +/- 3%. 4. Isolated type I cells exhibited the following characteristics: mean cell volume = 716 +/- 48 microns 3; diameter = 11.1 +/- 0.7 microns; and cell water content = 0.50 +/- 0.03 microliter/10(6) cells. 5. Taurine content of these alveolar type I cells was measured by HPLC. 6. The intracellular taurine concentration of type I cells was 0.14 +/- 0.07 mM, a value close to that of plasma (0.1 mM).

Animals↗
PubMed1990

Effects of in vitro ozone exposure on peroxidative damage, membrane leakage, and taurine content of rat alveolar macrophages.

Rat alveolar macrophages (AM) were isolated by pulmonary lavage, allowed to adhere to a tissue culture flask, and then exposed to 0.45 +/- 0.05 ppm ozone. After exposures ranging from 0 to 60 min, the medium was decanted and cells were harvested. Cells were assayed for oxidant damage and media analyzed for leakage of intracellular components. Increasing length of exposure to ozone resulted in a decreased number of adherent AM and decreased cell viability. Resting and zymosan-stimulated chemiluminescence increased immediately after ozone exposure and reached a maximum at 15-30 min, then declined to initial levels after 60 min of ozone exposure. Lipid peroxidation and leakage of protein and K+ ions increased with increasing length of exposure to ozone, while leakage of reduced and oxidized glutathione increased through 30 min, then declined (reduced) or leveled off (oxidized). Activity of the Na+/K+ ATPase decreased with time while intracellular taurine concentration exhibited an initial rise, peaked at 30 min, and then returned to the untreated level. Leakage of taurine into the medium increased with time of exposure, suggesting that exposure of AM to ozone results in a shift from bound to free intracellular taurine. These data indicate that in vitro exposure of AM to ozone results in a time-dependent alteration of cell function, membrane integrity, and viability.

Adenosine Triphosphatases↗
PubMed1990

Calcium transport in chicken leukocytes and erythrocytes.

1. In the present study, Ca2+ uptake and Ca2(+)-ATPase activity of two different chicken leukocyte populations and erythrocytes isolated from 1- to 6-week-old chickens were determined. 2. The Ca2(+)-ATPase activity of the two leukocyte populations significantly increased at 3 weeks of age. Erythrocyte Ca2(+)-ATPase activity significantly increased at 2 weeks of age. 3. Calcium transport activities into the two leukocyte populations did not differ significantly with age.

Aging↗
PubMed1990

Plasma cortisol is increased during the inhibition of LH secretion by central LHRH in the ewe.

The delayed and sustained suppression of LH secretion induced by the administration of LHRH into the third cerebral ventricle of the ovariectomized ewe suggests the activation of a neuroendocrine mechanism involving components separate from the LHRH system. Endogenous opioid peptides are involved in regulating LHRH secretion but our recent work shows they do not mediate this inhibition. There is, however, clear evidence for a role for each of the components of the hypothalamopituitary-adrenal axis in the suppression of LHRH/LH secretion. Thus, the relationship between the central administration of LHRH, changes in plasma cortisol and LH secretion was investigated. Injection of LHRH (21 pmol) into the third cerebral ventricle of ovariectomized ewes caused a significant and rapid rise in plasma cortisol to a maximum of 4-5 times pre-injection values, followed by a delayed but sustained reduction in LH secretion. There was a high correlation (r = -0.902) between the increase in cortisol and the reduction in LH. Both the stimulatory effect of central LHRH on plasma cortisol and the inhibitory effect on plasma LH were blocked by prior central treatment with an LHRH antagonist. Intravenous infusion of cortisol, to reach levels observed after central LHRH administration, reduced LH secretion (although not to the levels which followed central LHRH) due in part to a reduction in pituitary responsiveness to LHRH. These experiments provide evidence that cortisol, either alone or in combination with another component(s) of the hypothalamopituitary-adrenal axis, may play a role in the LHRH-induced inhibition of LHRH/LH secretion in the sheep.

Animals↗
PubMed1990

Central administration of corticotrophin-releasing factor in the sheep: effects on secretion of gonadotrophins, prolactin and cortisol.

Stress interferes with the normal secretion of LH and FSH from the anterior pituitary gland and therefore exerts a deleterious effect on reproductive function. Evidence suggests that the stress-induced disruption of gonadal function is due to a central action of corticotrophin-releasing factor (CRF) to inhibit the release of LHRH into the hypophysial-portal circulation. The following studies were undertaken to investigate further the role of CRF in regulating gonadotrophin release in the sheep and to determine whether central administration of this peptide can alter the secretion of other hormones (e.g. prolactin and cortisol) known to be released under conditions of stress. In contrast to other species, injection of CRF into the third ventricle of the sheep brain caused a dose-related stimulation of LH secretion. The pulse frequency and mean levels of LH were increased significantly following central administration of CRF. In contrast to this effect, central administration of CRF did not alter the plasma concentration of FSH but caused a marked and dose-related stimulation of prolactin and cortisol secretion. The stimulatory effect of CRF on prolactin secretion was reversed by i.v. administration of the opioid antagonist naloxone, suggesting that endogenous opioid peptides mediate the central effect of CRF on the release of prolactin, but not cortisol. In conclusion, these data demonstrate that administration of CRF causes a dose-related stimulation of LH and prolactin release from the anterior pituitary gland and cortisol from the adrenal gland. In the case of prolactin, endogenous opioid peptides are likely to mediate this response.(ABSTRACT TRUNCATED AT 250 WORDS)

Adrenal Glands↗
PubMed1989

Inhibitory effect of central LHRH on LH secretion in the ovariectomized ewe.

The role of central luteinizing hormone releasing hormone (LHRH) in the control of pulsatile LHRH and luteinizing hormone (LH) secretion was investigated in ovariectomized adult ewes. Injection of LHRH (2.1-21 pmol) into the third cerebral ventricle caused a delayed but sustained inhibition of LH secretion. Pulse frequency, pulse amplitude and mean LH levels were reduced significantly when compared with the responses to the control injection of saline (50 microliters). The inhibitory effect of centrally administered LHRH was not accompanied by a reduction in the pituitary responsiveness to intravenous LHRH. In contrast to the effect on LH, plasma levels of follicle-stimulating hormone (FSH) and prolactin were unaffected by central LHRH. The inhibitory action of LHRH was antagonized by prior injection of an LHRH antagonist ([N-Ac-D-Nal(2)1, D-p-Cl-Phe2, D-Trp3, D-hArg (Et2)6, D-Ala10] LHRH, 69 pmol) into the third ventricle. Central injection of the LHRH antagonist alone (at the same concentration) did not influence any characteristic of pulsatile LH secretion. In conclusion, these data indicate that exogenous administration of LHRH into the brain exerts a dose-related and receptor-mediated inhibition of LHRH pulse generator activity. However, the physiological significance of endogenous LHRH in the regulation of the LHRH pulse generator remains unresolved.

Animals↗
PubMed1988

Reversed-phase high-performance liquid chromatography technique for taurine quantitation.

Taurine (2-aminoethanesulfonic acid) was quantitated by reversed-phase chromatography on a C18 Resolve column using a linear gradient of 9-11% methanol in water. Glutamine was used as the internal standard. Pre-column derivatization of the amino acid with o-phthalaldehyde allowed the detection of as little as 0.1 pmol taurine. Dual ion-exchange column chromatography was employed to remove other amino acids and metabolic precursors of taurine from the samples. Cysteic acid and cysteine sulfinic acid did not interfere with taurine analysis by the high-performance liquid chromatographic method. For sample deproteinization, boiling and picric acid precipitation were used. Recovery of taurine averaged 93.5 +/- 5.0% (means +/- standard error of the mean) from standard solutions and was not affected by the method of deproteinization. Using this procedure, plasma taurine concentrations for the rat and chick were determined to be 100.7 +/- 13.1 microM and 108.0 +/- 0.3 microM, respectively. Recovery of taurine from plasma samples averaged 97.2 +/- 4.7%.

Animals↗
PubMed1975

Nature of the multiple forms of sweet-potato glucose phosphate isomerase.

The previously reported isoenzymes of sweet-potato glucose 6-phosphate isomerase were resolved by DEAE-cellulose chromatography. The multiple forms exhibited identical electrophoretic properties and electrofocused as a single component with an apparent isoelectric pH of 4.0. Chromatographic studies also suggest that the multiple forms do not represent true isoenzymes.

Glucose-6-Phosphate Isomerase↗